Sigilon Therapeutics Price on May 24, 2023
SGTXDelisted Stock | USD 21.11 0.33 1.54% |
If you're considering investing in Sigilon Stock, it is important to understand the factors that can impact its price. As of today, the current price of Sigilon Therapeutics stands at 21.11, as last reported on the 30th of November, with the highest price reaching 21.69 and the lowest price hitting 20.90 during the day. We have found thirty technical indicators for Sigilon Therapeutics, which you can use to evaluate the volatility of the company. Please validate Sigilon Therapeutics' Risk Adjusted Performance of 0.0957, coefficient of variation of 890.59, and Semi Deviation of 6.43 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
Sigilon Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Sigilon |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
SGTX |
Based on monthly moving average Sigilon Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sigilon Therapeutics by adding Sigilon Therapeutics to a well-diversified portfolio.
Related Headline
Apexigen Headline on 24th of May 2023
IPO Alert What to Know as Citigroup Plans Banamex Spinoff by investorplace.com
Citigroup stock is a hot topic among traders on Wednesday after the financial company said its considering an IPO for Banamex.
Sigilon Therapeutics Valuation on May 24, 2023
It is possible to determine the worth of Sigilon Therapeutics on a given historical date. On May 24, 2023 Sigilon was worth 7.05 at the beginning of the trading date compared to the closed value of 7.25. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Sigilon Therapeutics stock. Still, in general, we apply an absolute valuation method to find Sigilon Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sigilon Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Sigilon Therapeutics' related companies.
Open | High | Low | Close | Volume | |
6.34 | 9.32 | 6.34 | 7.31 | 57,066 | |
05/24/2023 | 7.05 | 7.34 | 6.91 | 7.25 | 8,714 |
7.19 | 7.19 | 5.58 | 5.59 | 30,872 |
Backtest Sigilon Therapeutics | | | Sigilon Therapeutics History | | | Sigilon Therapeutics Valuation | Previous | Next |
Sigilon Therapeutics Trading Date Momentum on May 24, 2023
On May 25 2023 Sigilon Therapeutics was traded for 5.59 at the closing time. The top price for the day was 7.19 and the lowest listed price was 5.58 . The trading volume for the day was 30.9 K. The trading history from May 25, 2023 was a factor to the next trading day price decrease. The trading price change against the next closing price was 22.90% . The trading price change against the current closing price is 38.76% . |
Sigilon Therapeutics Fundamentals Correlations and Trends
By evaluating Sigilon Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Sigilon Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Sigilon financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Sigilon Therapeutics Stock history
Sigilon Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sigilon is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sigilon Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sigilon Therapeutics stock prices may prove useful in developing a viable investing in Sigilon Therapeutics
Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Sigilon Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Sigilon Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 66 people.
Sigilon Therapeutics Stock Technical Analysis
Sigilon Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Sigilon Therapeutics Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Sigilon Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Sigilon Therapeutics November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Sigilon Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sigilon Therapeutics shares will generate the highest return on investment. By undertsting and applying Sigilon Therapeutics stock market strength indicators, traders can identify Sigilon Therapeutics entry and exit signals to maximize returns
Sigilon Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sigilon Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Sigilon Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sigilon to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0957 | |||
Jensen Alpha | 1.14 | |||
Total Risk Alpha | (2.99) | |||
Sortino Ratio | 0.7144 | |||
Treynor Ratio | 0.1568 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Sigilon Stock
If you are still planning to invest in Sigilon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sigilon Therapeutics' history and understand the potential risks before investing.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |